Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes

被引:10
作者
Rosa, Fausto [1 ,2 ]
Galiandro, Federica [1 ]
Ricci, Riccardo [2 ,3 ]
Di Miceli, Dario [4 ]
Quero, Giuseppe [1 ]
Fiorillo, Claudio [1 ]
Cina, Caterina [1 ]
Alfieri, Sergio [1 ,2 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Digest Surg, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Pathol, Rome, Italy
[4] Osped Buccheri La Ferla, Gen Surg, Palermo, Italy
关键词
Colorectal cancer; Cytoreductive surgery; HIPEC; Morbidity; Mortality; CURATIVE TREATMENT; LEARNING-CURVE; CARCINOMATOSIS; CANCER; MANAGEMENT; MORBIDITY; ORIGIN; MALIGNANCIES; MULTICENTER; PROGNOSIS;
D O I
10.1007/s00423-021-02353-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Peritoneal metastases carry the worst prognosis among all sites of colorectal cancer (CRC) metastases. In recent years, the advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival for selected patients with limited peritoneal involvement. We report the evolution of CRS and HIPEC for colorectal peritoneal metastases at a tertiary referral center over a 10-year period. Methods Patients with colorectal peritoneal metastases undergoing CRS and HIPEC were included and retrospectively analyzed at a tertiary referral center from January 2006 to December 2015. Main outcomes included evaluation of grade III/IV complications, mortality rate, overall and disease-free survival, and prognostic factors influencing survival on a Cox multivariate analysis. Results Sixty-seven CRSs were performed on 67 patients during this time for colorectal peritoneal metastases. The median patient age was 57 years with 55.2% being female. The median peritoneal carcinomatosis index (PCI) was 7, with complete cytoreduction achieved in 65 (97%) cases. Grade > 2 complications occurred in 6 cases (8.9%) with no mortality. The median overall survival for the entire cohort was 41 months, with a 3-year overall survival of 43%. In case of complete cytoreduction, median overall and disease-free survival were 57 months and 36 months respectively, with a 3-year disease-free survival of 62%. Complete cytoreduction and nonmucinous histology were key factors independently associated with improved overall survival. Conclusions CRS and HIPEC for limited peritoneal metastases from CRC are safe and effective, with acceptable morbidity. In selected patients, it offers a highly favorable long-term outcomes.
引用
收藏
页码:2797 / 2805
页数:9
相关论文
共 46 条
  • [1] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia
    Alzahrani, Nayef
    Ferguson, Jorgen S.
    Valle, Sarah J.
    Liauw, Winston
    Chua, Terence
    Morris, David L.
    [J]. ANZ JOURNAL OF SURGERY, 2016, 86 (11) : 937 - 941
  • [2] Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
    Casado-Adam, Angela
    Alderman, Robert
    Stuart, O. Anthony
    Chang, David
    Sugarbaker, Paul H.
    [J]. INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2011, 2011
  • [3] Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study
    Cashin, P. H.
    Graf, W.
    Nygren, P.
    Mahteme, H.
    [J]. EJSO, 2012, 38 (06): : 509 - 515
  • [4] PET or PET/CT for Detection of Peritoneal Carcinomatosis A Meta-Analysis
    Chang, Ming-Che
    Chen, Jin-Hua
    Liang, Ji-An
    Huang, Wen-Sheng
    Cheng, Kai-Yuan
    Kao, Chia-Hung
    [J]. CLINICAL NUCLEAR MEDICINE, 2013, 38 (08) : 623 - 629
  • [5] Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality
    Chua, Terence C.
    Yan, Tristan D.
    Saxena, Akshat
    Morris, David L.
    [J]. ANNALS OF SURGERY, 2009, 249 (06) : 900 - 907
  • [6] Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases Systematic review of all literature and meta-analysis of observational studies
    de Cuba, E. M. V.
    Kwakman, R.
    Knol, D. L.
    Bonjer, H. J.
    Meijer, G. A.
    te Velde, E. A.
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (04) : 321 - 327
  • [7] Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases
    Di Giorgio, Angelo
    De Iaco, Pierandrea
    De Simone, Michele
    Garofalo, Alfredo
    Scambia, Giovanni
    Pinna, Antonio Daniele
    Verdecchia, Giorgio Maria
    Ansaloni, Luca
    Macri, Antonio
    Cappellini, Paolo
    Ceriani, Valerio
    Giorda, Giorgio
    Biacchi, Daniele
    Vaira, Marco
    Valle, Mario
    Sammartino, Paolo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 914 - 922
  • [8] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [9] Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands
    Elferink, Marloes A. G.
    de Jong, Koert P.
    Klaase, Joost M.
    Siemerink, Esther J.
    de Wilt, Johannes H. W.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (02) : 205 - 212
  • [10] Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
    Elias, Dominique
    Gilly, Francois
    Boutitie, Florent
    Quenet, Francois
    Bereder, Jean-Marc
    Mansvelt, Baudouin
    Lorimier, Gerard
    Dube, Pierre
    Glehen, Olivier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 63 - 68